Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease

INTRODUCTION: People with Down syndrome (DS) are at high risk for Alzheimer's disease (AD). Defects in monoamine neurotransmitter systems are implicated in DS and AD but have not been comprehensively studied in DS. METHODS: Noradrenaline, adrenaline, and their metabolite 3-methoxy-4-hydroxyphen...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekker, Alain D., Vermeiren, Yannick, Carmona-Iragui, Maria, Benejam, Bessy, Videla, Laura, Gelpi, Ellen, Aerts, Tony, Van Dam, Debby, Fernández, Susana, Lleó, Alberto, Videla, Sebastian, Sieben, Anne, Martin, Jean-Jacques, Blesa, Rafael, Fortea, Juan, De Deyn, Peter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
CSF Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956808/
https://www.ncbi.nlm.nih.gov/pubmed/29780859
http://dx.doi.org/10.1016/j.dadm.2017.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956808/
https://www.ncbi.nlm.nih.gov/pubmed/29780859
http://dx.doi.org/10.1016/j.dadm.2017.11.001

Ejemplares similares